TrialFrontiers in endocrinology2022

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease.

Xingchun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.